Edwards Lifesciences

Open: 73.59 Close: 73.82 Change: 0.23

The unbelievably easy way to evaluate Edwards Lifesciences: Use an AI.

The game is changing. There is a new strategy to evaluate Edwards Lifesciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, price, EW, stock, revenue, Lifsciences, …

Concept Map

Semantic Network

Stock Summary

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes.

Today's Summary

Edwards Lifesciences stock price is $73.99 USD today. Current trend is moderately bearish and EW is experiencing buying pressure. Wall Street analysts predict that Edwards Lifsciences s share price could reach $82.80.

Today's News

Edwards Lifesciences stock price is $73.99 USD today. Current trend is moderately bearish and EW is experiencing buying pressure. Edwards Lifesciences had annual revenue of $5.38B with 2.86% growth in 2022. In the year 2022, Edwards Lifsciences. In December 7, 2024, the company announced its plans to spin-off its critical care unit. Edwards Lifesciences was raided by EU antitrust regulators at one of its facilities in an EU country a week ago, two people with direct knowledge of the matter told Reuters on Tuesday. Edwards Lifesciences Corp. edwards lifesciences corporation (ew) fell in q4 despite double-digit revenue growth. Edwards Lifsciences Corporation (EW) fell despite double digit revenue growth in Q4. One-month return of Edwards L.A. stock was -3.73%, and its shares lost 5.47%. Wall Street analysts predict that Edwards Lifesciences s share price could reach $82.80 by Jan 12, 2025. The average Edwards Lifsciences stock price prediction forecasts a potential upside of 11.91% from the current EW share price of $73.99. The companys revenue in 2024 is $5,819,000,000. Edwards Lifesciences has outperformed the market over the past 15 years by 8.14% on an annualized basis producing an average annual return of 20.36%. Shares of NYSE:EW opened at $74.03 on Friday. Edwards Lifesciences in Germany offers the following benefits: Competitive Compensation and Benefits package Flexible working hours, remote working pension plan Risk Insurance Meal Benefits Service Awards Enhanced Leave Benefits Transportation Benefits. 14 analysts have published ratings on Edwards Lifesciences (NYSE:EW), offering a diverse range of perspectives from bullish to bearish. Analysts have set 12-month price targets for Edwards, revealing an average target of $76.71. Edwards Lifesciences has an ROCE of 19% based on the trailing twelve months to September 2023. The returns on capital are good, but they havent moved much. Edwards has simply been reinvesting capital steadily. Edwards Lifesciences Corporation (EW) latest stock news & headlines - yahoo finance. We are hiring now. Edwards Lifesciences trades on the NYSE under the ticker symbol EW. Edwards Lifsciences has built a reputation for its innovative medical devices, particularly in the field of cardiovascular disease.

Stock Profile

"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California."

Keywords

How much time have you spent trying to decide whether investing in Edwards Lifesciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, price, EW, stock, revenue, Lifsciences, and the most common words in the summary are: edward, lifesciences, stock, market, ew, job, company, . One of the sentences in the summary was: Wall Street analysts predict that Edwards Lifsciences s share price could reach $82.80.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #edward #lifesciences #stock #market #ew #job #company.